DIRS.INFO The most relevant business & tech news

☆ Humana could be top retail Medicare Advantage prescription drug plan, Morgan Stanley says in upgrade
▼ + stars: | 2022-09-20 | by ( Sarah Min | ) www.cnbc.com time to read: +1 min

It's time to buy Humana , which could be the top retail Medicare Advantage prescription drug plan, according to Morgan Stanley. Analyst Michael Ha upgraded the stock to overweight from equal weight, saying Humana's improved competitive position will drive earnings growth for the company. "Based on our proprietary analysis of Medicare Advantage (MA) benefit richness, we believe Humana's 2023 plan value increases are not only the highest in recent history but also positions the company as the #1 Ranked Retail Medicare Advantage prescription drug (MA-PD) plan in benefit richness amongst peers (vs. #5 ranking in the previous four years)," Ha added. Shares of Humana outperformed the broader market this year, up 8%, but the analyst expects that the health insurance company's improved offerings will drive membership growth next year. The analyst raised his price target on Humana to $549 up from $494, implying that shares can advance roughly 9.6% from Monday's closing price of $501.07.

☆ Traders worry there are more earnings warnings like FedEx's about to come out
▼ + stars: | 2022-09-19 | by ( Bob Pisani | ) www.cnbc.com time to read: +4 min

Michael Hartnett at Bank of America said that for the S & P 500, "we say nibble at SPX 3600, bite at 3300, gorge at 3000." The S & P 500 closed Friday at 3,873, and the June 16 bottom was 3,666, so 3,300 and 3,000 are a ways away. What about 3,000, the level Hartnett suggested investors should "gorge" on the S & P 500? A much lower multiple with a contraction in earnings: That is what you call a recessionary earnings picture. Bottom line: Lower mortgage rates definitely have been a factor in higher home prices for some time.

☆ MLB roundup: Aaron Judge belts 2 more HRs in Yankees' win
▼ + stars: | 2022-09-19 | by ( ) www.reuters.com time to read: +10 min

Gerrit Cole (12-7) earned the win with four hits, four runs, three walks and eight strikeouts in five innings. Eloy Jimenez had three hits, including a two-run home run, and drove in three runs. Willi Castro hit a two-run homer and Javier Baez had a solo shot for the Tigers. Rays 5, Rangers 3Christian Bethancourt and Jose Siri hit back-to-back homers in host Tampa Bay's win over Texas. The duo went deep in the second inning for a 2-1 lead that the Rays never relinquished.

☆ How the mind of an 80-year-old president is biologically different from a 45-year-old president's
▼ + stars: | 2022-09-13 | by ( Kimberly Leonard | ) www.businessinsider.com time to read: +23 min

It was 1988, and he'd approached President Ronald Reagan in the Cabinet room at the White House. People scoffed at the glowing hourlong media conference that President Donald Trump's White House doctor gave about his health. Reagan publicly announced he had Alzheimer's disease five years after he left the White House. Francis Shen, who teaches psychiatry at Harvard Medical School's Center for Bioethics, would like to see information about political leaders' cognitive health made public. Cognitive health should be no different, he said, because it also might affect the way presidents and members of Congress make important decisions.

☆ The best investing stories of July: How to win the next phase of COVID-19 — 'hidden' high-upside businesses — record-cheap value stocks
▼ + stars: | 2020-08-04 | by ( Business Insider | ) www.businessinsider.com time to read: +4 min

Many of them are preparing for the next phase of life in the stock market — one characterized by stimulus uncertainty and a US economic recovery that's lagging the rest of the world. He foresees a so-called squeeze higher for value stocks, and recommends that investors position their portfolios to profit from a rotation away from popular growth names. Look no further:Chart of the weekJPMorganThe JPMorgan chart above — compiled by the firm's quant guru, Marko Kolanovic — shows that value stocks are now trading at a record cheapness relative to growth. Kolanovic's takeaway from this trend is that value stocks are susceptible to a squeeze higher, and investors should rightly position their portfolios ahead of time. — Marko Kolanovic, global head of macro quantitative and derivatives research at JPMorgan, on why he sees a value-stock rally in the cards

☆ The definitive guide to getting started in real-estate investing
▼ + stars: | 2020-07-21 | by ( Business Insider | ) www.businessinsider.com time to read: +4 min

But have you ever considered real-estate investing? If you aren't yet a subscriber to Investing Insider, you can sign up here. Our research culminated in a definitive guide to getting into real-estate investing. Among Mittal's funds is the StocksPlus Long Duration Fund, which consistently beats 99% of peers. — Bill Miller, the founder of Miller Value Partners, whose record-setting fund trounced the market for 15 consecutive years

Search resuls for: "Michael Ha"

6 mentions found